Clinical Trial Update: Personalised Immunotherapy Platform

View source ↗

Summary

Clinical trial update for a personalised immunotherapy platform; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Cutaneous Squamous Cell Carcinoma
• Melanoma
• Merkel Cell Carcinoma
• Solid Tumor

Snippet

Sponsor: Melanoma Institute Australia | Conditions: Melanoma, Cutaneous Squamous Cell Carcinoma | Status: RECRUITING